Clinical Trials Sponsored by Biomet U.K. Ltd

Total 344 results

Zimmer Biomet
Biomet U.K. Ltd.

Terminated

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Femoral Neck Fractures

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

ReCap Total Hip Resurfacing Prospective Data Collection

Arthritis

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Completed

A Randomized Control Trial to Assess Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Implant Designs

Osteoarthritis

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Completed

A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Withdrawn

Retrospective Data Review of ReCap Total Hip Resurfacing

Osteoarthritis of the Hip
Zimmer Biomet
Hvidovre University Hospital; Biomet U.K. Ltd.

Withdrawn

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

Osteoarthritis
Zimmer Biomet
East Sussex Hospitals NHS Trust; Biomet U.K. Ltd.

Active, not recruiting

Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants (Vanguard)

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis

United Kingdom
Ingemar Ivarsson
Biomet U.K. Ltd.

Completed

Taperloc Versus Taplerloc Microplasty

Osteoarthritis

Sweden
Remedor Biomed Ltd

Completed

Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers (Remede d'Or)

Diabetic Foot Ulcer

Israel
Prima BioMed Ltd

Completed

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study (CAN-003X)

Epithelial Ovarian Cancer

United States, Australia
Prima BioMed Ltd

Completed

Ovarian Cancer Vaccine for Patients in Remission

Epithelial Ovarian Cancer

United States, Australia
Prima BioMed Ltd

Withdrawn

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Pancreatic Carcinoma Stage I | Pancreatic Carcinoma Stage II
Prima BioMed Ltd

Terminated

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment (CANVAS)

Epithelial Ovarian Cancer

United States, Australia
BioMAS Ltd

Withdrawn

Topical Application of AS101 for the Treatment of Psoriasis

Mild to Moderate Psoriasis

Israel
BioMAS Ltd

Suspended

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Israel
BioMAS Ltd

Terminated

Topical Application of AS101 for the Treatment of Atopic Dermatitis

Atopic Dermatitis

Israel
BioMAS Ltd

Completed

Safety and Efficacy Study to Test Topical AS101 for External Genital Warts

Condyloma Acuminata | Wart; External Genital Organs

Israel
BIOrest Ltd.

Unknown

BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (BLADE)

Diabetes Mellitus

Israel
BioMAS Ltd

Unknown

Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts

External Genital Warts

Israel
BioMAS Ltd

Terminated

Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

Chemotherapy Induced Thrombocytopenia

Israel
UnicoCell Biomed CO. LTD

Recruiting

Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis

Knee Osteoarthritis

Taiwan
Biobeat Technologies Ltd.

Completed

Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor

Acute Cardiac Event | Acute Cardiac Failure | Acute Cardiac Pulmonary Edema

Israel
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Solid Tumors
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Biobeat Technologies Ltd.

Completed

Early Warning of Intradialytic Hypotension in Hemodialysis Patients

Hypotension of Hemodialysis

Israel
Panacea Biotec Ltd

Unknown

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

Diabetes Mellitus

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fasting Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

Healthy Volunteers

India
Biobeat Technologies Ltd.

Completed

Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients

Congestive Heart Failure

Israel
Biobeat Technologies Ltd.

Completed

Comparing PPG-based Blood Pressure Measurement to the Gold Standard Manometer

Hypertension | Blood Pressure Disorders

Israel
Biohit Healthcare Ltd

Unknown

Gastropanel for Gastric Atrophy and Cancer Risk Assessment

Stomach Neoplasms | Gastritis, Atrophic

United Kingdom
Panacea Biotec Ltd

Completed

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

Hemorrhoids

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

Healthy Volunteers

India
Panacea Biotec Ltd

Completed

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

Healthy Volunteers

India
NightstaRx Ltd, a Biogen Company

Completed

Natural History of the Progression of Choroideremia Study (NIGHT)

Choroideremia

Finland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France
Beijing StarMab Biomed Technology Ltd

Recruiting

Clinical Study of SM3321 With Solid Tumors

Locally Advanced or Metastatic Solid Tumors

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Trial of HBM9378 in Healthy Chinese Subjects

Asthma

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (MG)

Myasthenia Gravis

China

3

Subscribe